- Home
- ORGO vs MCI Comparison
ORGO vs MCI Comparison
Compare ORGO & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- MCI
- Stock Information
- Founded
- ORGO 1985
- MCI 1971
- Country
- ORGO United States
- MCI United States
- Employees
- ORGO N/A
- MCI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- MCI Trusts Except Educational Religious and Charitable
- Sector
- ORGO Health Care
- MCI Finance
- Exchange
- ORGO Nasdaq
- MCI Nasdaq
- Market Cap
- ORGO 408.3M
- MCI 400.8M
- IPO Year
- ORGO N/A
- MCI N/A
- Fundamental
- Price
- ORGO $3.86
- MCI $20.17
- Analyst Decision
- ORGO Strong Buy
- MCI
- Analyst Count
- ORGO 3
- MCI 0
- Target Price
- ORGO $5.33
- MCI N/A
- AVG Volume (30 Days)
- ORGO 572.4K
- MCI 40.4K
- Earning Date
- ORGO 11-12-2024
- MCI 01-01-0001
- Dividend Yield
- ORGO N/A
- MCI 8.46%
- EPS Growth
- ORGO N/A
- MCI N/A
- EPS
- ORGO N/A
- MCI 1.82
- Revenue
- ORGO $455,038,000.00
- MCI N/A
- Revenue This Year
- ORGO $7.42
- MCI N/A
- Revenue Next Year
- ORGO $0.08
- MCI N/A
- P/E Ratio
- ORGO N/A
- MCI $9.88
- Revenue Growth
- ORGO 1.34
- MCI N/A
- 52 Week Low
- ORGO $2.17
- MCI $12.96
- 52 Week High
- ORGO $4.71
- MCI $19.24
- Technical
- Relative Strength Index (RSI)
- ORGO 63.24
- MCI 60.60
- Support Level
- ORGO $3.63
- MCI $18.60
- Resistance Level
- ORGO $4.57
- MCI $19.89
- Average True Range (ATR)
- ORGO 0.26
- MCI 0.48
- MACD
- ORGO 0.11
- MCI 0.01
- Stochastic Oscillator
- ORGO 60.99
- MCI 87.71
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
About MCI Barings Corporate Investors
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. These investments are typically made to small or middle market companies. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.